The $20 million will be used to accelerate three ongoing clinical trials by the company for Covid-19 vaccines and cancer treatments. In January, GeoVax raised $10 million for the same clinical trials.
from Bizjournals.com Feed (2019-07-18 12:47:42) https://www.bizjournals.com/atlanta/news/2022/07/08/smyrna-biotech-company-raises-20m-to-expand-clini.html?ana=brss_609
Mold Remediation Pros
No comments:
Post a Comment